La Madonnina Clinic
La Madonnina Clinic
Italia, Milano
| Italia | Turchia | Austria | |
| Terapia ormonale | da $2,500 | da $406 | da $7,000 |
| Terapia con cellule staminali | da $10,000 | da $4,675 | da $8,500 |
| Resezione della cistifellea | da $7,000 | da $2,900 | da $9,000 |
| Aferesi selettiva | da $3,100 | da $1,550 | - |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Malattia di Crohn. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Malattia di Crohn e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Malattia di Crohn.
Il medico è un gastroenterologo distinto e ricercatore clinico specializzato in endoscopia gastrointestinale e gastroenterologia. Laureatosi presso la Facoltà di Medicina dell'Università di Belgrado, il medico ha completato una borsa di studio in gastroenterologia e ha conseguito i titoli di MSc e PhD lì. Il medico ha guidato l'endoscopia GI presso la Clinica Universitaria di Belgrado dal 2007 al 2012 e ha servito come Vice Direttore Medico del Centro di Endoscopia Digestiva presso il Centro Ospedaliero Accademico di Udine dal 2013 al 2019.<\/p>
Gli interessi clinici includono l'endoscopia terapeutica e interventistica, le malattie colorettali, la pancreatite cronica e l'oncologia gastrointestinale. La ricerca si concentra su tecniche innovative di endoscopia terapeutica, screening del CRC, carcinogenesi pancreatica e terapia personalizzata per l'obesità.<\/p>
Il medico è specialista in Gastroenterologia e Chirurgia Bariatrica presso la Clinica Madonnina di Milano, Italia. Con un focus clinico su condizioni come Gastrite, Ascite, Obesità, Ulcera Gastrica e Cancro del Colon, il medico è dedicato a fornire cure esperte in queste aree.<\/p>
Advanced Crohn's disease treatments in Italy include IL-23 inhibitors like Risankizumab and oral JAK inhibitors such as Upadacitinib. Specialized centers offer stem cell therapy for refractory cases. Leading facilities in Milan and Rome provide biologic therapies, clinical trials, and gut-selective integrin inhibitors for targeted inflammation control.
Bookimed Expert Insight: While many search for the newest drugs, the real advantage in Italy is the integration of research hubs. Mater Olbia Hospital in Rome combines expertise from the Qatar Foundation and Fondazione Policlinico Gemelli. This partnership allows patients to access clinical trials for advanced combination treatments (ACT). These protocols use multiple biologics simultaneously for cases that do not respond to standard care.
Patient Consensus: Patients note that seeking private consultations can significantly shorten wait times for high-demand biologics like Ustekinumab. Many suggest preparing detailed flare history and medical records to fast-track approvals within specialized regional networks.
Italy hosts leading centers for Crohns disease specializing in biological therapies and advanced diagnostics. Humanitas Research Hospital and Agostino Gemelli University Policlinic serve as primary referral hubs. These facilities utilize multidisciplinary teams including specialized surgeons and gastroenterologists to manage complex inflammatory bowel conditions.
Bookimed Expert Insight: Patients seeking premium care often choose La Madonnina Clinic in Milan. It is part of the San Donato Network and treats high-profile individuals. While it is a private facility, its link to major research networks ensures access to top experts. This presents a faster alternative to public university hospitals where wait times are often significant.
Patient Consensus: Patients often recommend choosing university-affiliated hospitals over general facilities for better specialty care. Many note that northern Italian hospitals typically offer more updated medical protocols than southern regions.
Italy supports Crohn's disease care through the Servizio Sanitario Nazionale (SSN). It classifies the condition as a chronic illness. This status grants patients a ticket exemption for diagnostic tests and specialist visits. The system fully subsidizes biological therapies and surgical procedures in public hospitals.
Bookimed Expert Insight: Patients can navigate regional wait times by using Italy's cross-regional referral system. If a local facility is overbooked, the SSN may authorize and fund treatment in other regions. This is especially useful for complex surgeries at high-volume centers like Mater Olbia Hospital. Utilizing this legislative right ensures timely access to specialized gastroenterology teams without incurring private surgical fees.
Patient Consensus: Patients note that registering with a regional IBD hub provides a dedicated coordinator. This significantly simplifies scheduling appointments and obtaining prescriptions compared to managing standard public referrals alone.